https://www.selleckchem.com/pr....oducts/gsk591-epz015
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease ranging from steatosis, steatohepatitis, fibrosis and eventually cirrhosis. Leukocyte cell-derived chemotaxin 2 (LECT2), a new hepatokine, may be involved in energy metabolism. This study aims to 1) evaluate the association between LECT2 and NAFLD in multiple models; and 2) investigate the role of circulating LECT2 in the development of NAFLD in a multi-center cohort study. Western blotting, qPCR and ELISA were performed to evaluate hepatic an
Like
Comment
Share
